Patents by Inventor Andreas H. Sarris

Andreas H. Sarris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating lymphoma
    Patent number: 7887836
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: February 15, 2011
    Assignees: Hana Biosciences, Inc., Board of Regents, The University of Texas System
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
  • Compositions and methods for treating cancer
    Patent number: 7311924
    Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: December 25, 2007
    Assignee: Hana Biosciences, Inc.
    Inventors: Andreas H Sarris, Fernando Cabanillas, Patricia M Logan, Clive T R Burge, James H Goldie, Murray S Webb, Thomas D Madden, Sean C Semple, Quet F Ahkong, Sandra K Klimuk
  • Compositions and methods for treating lymphoma
    Patent number: 7247316
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: July 24, 2007
    Assignees: Board of Regents, The University of Texas System, Inex Pharmaceuticals Corporation
    Inventors: Andreas H Sarris, Fernando Cabanillas, Patricia M Logan, Clive T R Burge, James H Goldie, Murray S Webb
  • Compositions and methods for treating lymphoma
    Patent number: 7244450
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: July 17, 2007
    Assignees: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas System
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
  • Compositions and methods for treating lymphoma
    Publication number: 20040253302
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Application
    Filed: December 4, 2003
    Publication date: December 16, 2004
    Applicants: Board of Regents, The University of Texas System, Inex Pharmaceuticals Corporation
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T.R. Burge, James H. Goldie, Murray S. Webb
  • Compositions and methods for treating lymphoma
    Publication number: 20040228909
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Application
    Filed: February 18, 2004
    Publication date: November 18, 2004
    Applicants: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas System
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
  • Compositions and methods for treating lymphoma
    Patent number: 6723338
    Abstract: This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin's Lymphoma. These methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, to a mammal with a lymphoma.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: April 20, 2004
    Assignees: Inex Pharmaceuticals Corporation, Board of Regents, The University of Texas System
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb
  • Compositions and methods for treating cancer
    Publication number: 20040071768
    Abstract: This invention provides compositions and methods for treating neoplasias in a mammal. In particular, the invention provides liposome-encapsulated vinca alkaloids, e.g., vinorelbine, and methods of treating a mammal using such compositions.
    Type: Application
    Filed: April 3, 2003
    Publication date: April 15, 2004
    Applicants: Inex Pharmaceuticals Corporation, The University of Texas, MD Anderson Cancer Center
    Inventors: Andreas H. Sarris, Fernando Cabanillas, Patricia M. Logan, Clive T. R. Burge, James H. Goldie, Murray S. Webb, Thomas D. Madden, Sean C. Semple, Quet F. Ahkong, Sandra K. Klimuk
  • Methods and compositions incorporating IP-10
    Patent number: 5728377
    Abstract: The present invention discloses the correct processing of IP-10, a myelosuppressive protein produced by certain cells such as keratinocytes, monocytes and human endothelial cells upon stimulation by .gamma.-interferon. Also disclosed is a method of treating human cancer patients by applying IP-10 in a pharmaceutical composition in conjunction with certain antineoplastic agents.
    Type: Grant
    Filed: July 20, 1993
    Date of Patent: March 17, 1998
    Assignees: Board of Regents, The University of Texas System, Indiana University Foundation, Sloan-Kettering Institute for Cancer Research
    Inventors: Andreas H. Sarris, Hal E. Broxmeyer, Jeff V. Ravetch